MedPath
FDA Approval

ENTERO Vu 24%

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
E-Z-EM Canada Inc
DUNS: 204211163
Effective Date
January 17, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Barium sulfate(240 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

E-Z-EM, INC.

002041226

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

E-Z-EM Canada Inc

E-Z-EM Canada Inc

E-Z-EM, INC.

204211163

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ENTERO Vu 24%

Product Details

NDC Product Code
32909-145
Application Number
NDA208143
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
October 7, 2020
Code: 25BB7EKE2EClass: ACTIBQuantity: 240 mg in 1 mL
ACACIAInactive
Code: 5C5403N26OClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
CARRAGEENAN SODIUMInactive
Code: 7CY8BVL34NClass: IACT
METHYLCELLULOSE (400 MPA.S)Inactive
Code: O0GN6F9B2YClass: IACT
DIMETHICONE 350Inactive
Code: 2Y53S6ATLUClass: IACT
DIMETHICONE 1000Inactive
Code: MCU2324216Class: IACT
POTASSIUM CHLORIDEInactive
Code: 660YQ98I10Class: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4Class: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
XANTHAN GUMInactive
Code: TTV12P4NEEClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT

ENTERO Vu 24%

Product Details

NDC Product Code
32909-146
Application Number
NDA208143
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
October 7, 2020
Code: 25BB7EKE2EClass: ACTIBQuantity: 240 mg in 1 mL
ACACIAInactive
Code: 5C5403N26OClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
XANTHAN GUMInactive
Code: TTV12P4NEEClass: IACT
CARRAGEENAN SODIUMInactive
Code: 7CY8BVL34NClass: IACT
DIMETHICONE 350Inactive
Code: 2Y53S6ATLUClass: IACT
DIMETHICONE 1000Inactive
Code: MCU2324216Class: IACT
METHYLCELLULOSE (400 MPA.S)Inactive
Code: O0GN6F9B2YClass: IACT
POTASSIUM CHLORIDEInactive
Code: 660YQ98I10Class: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4Class: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
© Copyright 2025. All Rights Reserved by MedPath